US (re)insurance stocks follow Europe in Covid-19 vaccine surge
US (re)insurance stocks surged higher at the open, adding to a global market rally fuelled by news from drugmaker Pfizer and BioNTech on a breakthrough in the race to find a vaccine for Covid-19.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below